Cardinal Health INC Form 4 insider transactions
NYSE
Cardinal Health Inc. director Akhil Johri was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director Patricia Hemingway Hall was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director David C. Evans was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director Sheri H. Edison was granted 1,067 restricted share units, increasing her beneficial ownership to 14,848 common shares.
NYSE
Cardinal Health director Michelle Brennan was granted 1,067 restricted share units, increasing her direct beneficial ownership to 8,086 common shares.
NYSE
Cardinal Health Director Robert Azelby was granted 1,067 restricted share units, vesting in November 2026, as reported in a recent SEC Form 4 filing.
NYSE
Cardinal Health's CEO of the PSS Segment, Deborah Weitzman, sold 21,367 common shares for approximately $3.2 million on August 20, 2025.
NYSE
Cardinal Health CEO Jason Hollar sold 35,901 common shares for approximately $5.4 million in pre-planned transactions.
NYSE
Cardinal Health's Chief Accounting Officer reported the sale of common shares and the acquisition of restricted share units.
NYSE
Cardinal Health's Chief Information Officer, Michelle D. Greene, reported the acquisition of restricted stock units and subsequent sales of common shares.
NYSE
Cardinal Health's CEO of GMPD Segment, Stephen M. Mason, reported the acquisition of restricted stock units and subsequent sales of common shares, including tax-related withholdings.
NYSE
Cardinal Health's PSS Segment CEO, Deborah Weitzman, received a grant of restricted share units and had shares withheld for tax obligations related to vested units.
NYSE
Cardinal Health CEO Jason M. Hollar reported the sale of over 100,000 common shares following a significant RSU grant and tax-related share withholding.
NYSE
Cardinal Health's Chief Legal/Compliance Officer, Jessica L. Mayer, reported the acquisition of restricted stock units and subsequent sales of common shares.
NYSE
Cardinal Health's Chief Financial Officer, Aaron E. Alt, reported the sale of over 48,000 common shares following the vesting of equity awards.
NYSE
Cardinal Health's Chief Human Resources Officer, Ola M. Snow, reported significant sales of common shares following RSU grants and tax withholdings.
NYSE
Cardinal Health's Chief Information Officer, Michelle D. Greene, reported the future vesting of 16,362 performance share units set to settle on August 15, 2025.
NYSE
Deborah Weitzman, CEO of Cardinal Health's PSS Segment, reported the acquisition of 39,100 performance share units set to settle in August 2025.
NYSE
Cardinal Health's Chief Human Resources Officer, Ola M. Snow, acquired 31,813 common shares through a performance share unit grant.
NYSE
Cardinal Health's Chief Accounting Officer, Mary C. Scherer, acquired 3,029 common shares through a performance share unit settlement.
NYSE
Cardinal Health's Chief Legal Officer, Jessica L. Mayer, was granted 49,994 performance share units, set to settle in August 2025.
NYSE
Cardinal Health's CEO of GMPD Segment, Stephen M. Mason, is set to acquire 54,537 common shares through performance share units.
NYSE
Cardinal Health's CEO, Jason M. Hollar, acquired 245,420 common shares through a performance share unit grant, settling on August 15, 2025.
NYSE
Cardinal Health's Chief Financial Officer, Aaron E. Alt, is set to acquire 67,448 common shares through performance share unit settlement.
NYSE
Jessica L. Mayer, Chief Legal/Compliance Officer of Cardinal Health Inc., disposed of 5,176 common shares valued at $167.18 per share to cover tax withholding obligations related to deferred performance share units.
NYSE
Stephen M. Mason, CEO of Cardinal Health's GMPD Segment, reported the disposition of 5,694 common shares to satisfy tax withholding obligations, while also granting a Limited Power of Attorney for future SEC reporting.
NYSE
Cardinal Health CEO Jason M. Hollar disposed of 5,821 common shares to cover tax withholding obligations related to performance share units.
NYSE
Cardinal Health's Chief Human Resources Officer, Ola M. Snow, disposed of 3,623 common shares valued at $167.18 per share to cover tax withholding obligations related to performance share units.
NYSE
Director Ramakrishna Sudhakar reports the acquisition of 1,049 restricted share units in Cardinal Health, vesting on March 15, 2026.
NYSE
Robert W. Musslewhite, a director at Cardinal Health, reports the acquisition of 1,049 restricted share units on March 15, 2025, which will vest on March 15, 2026.